title: Distinct domains in ORF52 tegument protein mediate essential functions in murine gammaherpesvirus 68 virion tegumentation and secondary envelopment.
abstract: Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus are etiologically associated with several types of human malignancies. However, as these two human gammaherpesviruses do not replicate efficiently in cultured cells, the morphogenesis of gammaherpesvirus virions is poorly understood. Murine gammaherpesvirus 68 (MHV-68) provides a tractable model to define common, conserved features of gammaherpesvirus biology. ORF52 of MHV-68 is conserved among gammaherpesviruses. We have previously shown that this tegument protein is essential for the envelopment and egress of viral particles and solved the crystal structure of ORF52 dimers. To more closely examine its role in virion maturation, we performed immunoelectron microscopy of MHV-68-infected cells and found that ORF52 localized to both mature, extracellular virions and immature viral particles in the cytoplasm. ORF52 consists of three α-helices followed by one β-strand. To understand the structural requirements for ORF52 function, we constructed mutants of ORF52 and examined their ability to complement an ORF52-null MHV-68 virus. Mutations in conserved residues in the N-terminal α1-helix and C terminus, or deletion of the α2-helix, resulted in a loss-of-function phenotype. Furthermore, the α1-helix was crucial for the predominantly punctate cytoplasmic localization of ORF52, while the α2-helix was a key domain for ORF52 dimerization. Immunoprecipitation experiments demonstrated that ORF52 interacts with another MHV-68 tegument protein, ORF42; however, a single point mutation in R95 in the C terminus of ORF52 led to the loss of this interaction. Moreover, the homologues of MHV-68 ORF52 in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus complement the defect in ORF52-null MHV-68 and interact with MHV-68 ORF52. Taken together, these data uncover the relationship between the α-helical structure and the molecular basis for ORF52 function. This is the first structure-based functional domain mapping study for an essential gammaherpesvirus tegument protein.
authors.affiliation: Chinese Academy of Sciences Key Laboratory of Infection and Immunity, Institute of Biophysics, Beijing, People's Republic of China.
authors.forename: Lili
authors.initials: L
authors.lastname: Wang
authors.forename: Haitao
authors.initials: H
authors.lastname: Guo
authors.forename: Nichole
authors.initials: N
authors.lastname: Reyes
authors.forename: Shaoying
authors.initials: S
authors.lastname: Lee
authors.forename: Eric
authors.initials: E
authors.lastname: Bortz
authors.forename: Fengli
authors.initials: F
authors.lastname: Guo
authors.forename: Ren
authors.initials: R
authors.lastname: Sun
authors.forename: Liang
authors.initials: L
authors.lastname: Tong
authors.forename: Hongyu
authors.initials: H
authors.lastname: Deng
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D006224:Cricetinae; D017931:DNA Primers; D018142:Gammaherpesvirinae / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D008969:Molecular Sequence Data; D016366:Open Reading Frames; D017354:Point Mutation; D011485:Protein Binding; D060888:Real-Time Polymerase Chain Reaction; D017386:Sequence Homology, Amino Acid; D014764:Viral Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D014771:Virion / Q000378:metabolism*; D014779:Virus Replication
chemical_list: D017931:DNA Primers; D014764:Viral Proteins
references.citation: J Virol. 2000 Aug;74(15):6964-74
references.pmid: 10888635
references.citation: J Virol. 1997 Aug;71(8):5894-904
references.pmid: 9223479
references.citation: J Biol Chem. 2007 Oct 26;282(43):31534-41
references.pmid: 17699518
references.citation: Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16286-91
references.pmid: 15534216
references.citation: J Virol. 2002 Jun;76(12):6244-56
references.pmid: 12021358
references.citation: J Virol. 2008 May;82(10):4742-50
references.pmid: 18321973
references.citation: J Virol. 2005 Jan;79(2):800-11
references.pmid: 15613308
references.citation: J Virol. 2005 Aug;79(15):9566-71
references.pmid: 16014918
references.citation: Virus Res. 2004 Dec;106(2):167-80
references.pmid: 15567495
references.citation: J Struct Biol. 2008 Mar;161(3):428-38
references.pmid: 18096403
references.citation: J Virol. 2000 Apr;74(8):3659-67
references.pmid: 10729142
references.citation: Science. 2006 Jan 13;311(5758):239-42
references.pmid: 16339411
references.citation: J Virol. 2002 Feb;76(4):1537-47
references.pmid: 11799148
references.citation: J Gen Virol. 1990 Jun;71 ( Pt 6):1365-72
references.pmid: 2161903
references.citation: Curr Opin Microbiol. 1999 Aug;2(4):403-9
references.pmid: 10458986
references.citation: J Virol. 2005 Nov;79(22):14383-91
references.pmid: 16254372
references.citation: J Virol. 2003 Dec;77(24):13425-32
references.pmid: 14645600
references.citation: J Neurochem. 2005 Sep;94(5):1306-14
references.pmid: 16111479
references.citation: J Biomed Biotechnol. 2011;2011:926258
references.pmid: 21197474
references.citation: Nat Protoc. 2007;2(10):2480-91
references.pmid: 17947990
references.citation: Cancer Treat Res. 2001;104:89-126
references.pmid: 11191137
references.citation: J Virol. 2007 Sep;81(18):10137-50
references.pmid: 17634243
references.citation: Adv Cancer Res. 2001;81:161-200
references.pmid: 11430595
references.citation: Protein Cell. 2010 Nov;1(11):987-98
references.pmid: 21153516
references.citation: Vet Microbiol. 2006 Mar 31;113(3-4):163-9
references.pmid: 16330166
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3805-10
references.pmid: 15738413
references.citation: Curr Opin Microbiol. 2006 Aug;9(4):423-9
references.pmid: 16814597
references.citation: Trends Microbiol. 1998 Jul;6(7):276-82
references.pmid: 9717216
references.citation: Virology. 2008 Sep 1;378(2):347-54
references.pmid: 18602131